Hemodialysis. Chronic kidney disease, stage 5
Conditions
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Hemodialysis for minimum 3 months Normal Gastrointestinal system & absence of GI complaints Tendency to participate in study No-entry of patients with bleeding tendency, eg, Aspirin or Warfarin or NOVAK use No-entry of patients with hepatobilliary diseases No-entry of patients in Immunosuppressive drugs
Exclusion criteria
Exclusion criteria: Pregnant or lacating patients Dont tendency to participating Observation of any side effects, develop any non-entry conditions during the study Consumption of less than 90% curcumin-piperine supplement Side effects that can lead to stopping the plan or withdrawing the subject from the study after taking the supplement Causing any unwanted digestive problems including stomachache, heartburn, nausea, vomiting, diarrhea or others Causing any kind of sensitivity in skin, respiratory or otherwise Any side effects that did not exist before taking the supplement History of allergy to turmeric compounds Active cancer Recent surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total antioxidant capacity (TAC) serum level. Timepoint: Begining and three months after starting to take the supplement. Method of measurement: ELISA.;Superoxide Dismutase (SOD) serum level. Timepoint: Begining and three months after starting to take the supplement. Method of measurement: ELISA.;Malondialdehyde (MDA) serum level. Timepoint: Begining and three months after starting to take the supplement. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFirouzeh Moeinzadeh
Esfahan University of Medical Sciences
Outcome results
None listed